5-Morpholinopyrimidine-2,4(1H,3H)-dione

Catalog No. :
ACWNOT394
CAS No. :
37454-52-7
Molecular Formula :
C8H11N3O3
Molecular Weight :
197.19

IUPAC Name:5-morpholinopyrimidine-2,4(1H,3H)-dione

5-Morpholinopyrimidine-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$109.00Login to see priceInquiryInquiry
100mg97%$154.00Login to see priceInquiryInquiry
250mg97%$211.00Login to see priceInquiryInquiry
1g97%$411.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Morpholinopyrimidine-2,4(1H,3H)-dione
IUPAC Name5-morpholinopyrimidine-2,4(1H,3H)-dione
MDL No.MFCD00233546
Molecular FormulaC8H11N3O3
Molecular Weight197.19
SMILESO=C1NC(C(N2CCOCC2)=CN1)=O
InChI KeySIVJYKAWVLZRSX-UHFFFAOYSA-N
Synonym5-morpholinopyrimidine-2,4(1H,3H)-dione;5-Morpholin-4-yl-1H-pyrimidine-2,4-dione;5-(morpholin-4-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione;2,4(1H,3H)-Pyrimidinedione, 5-(4-morpholinyl)-
CAS No.37454-52-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWNOT394 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWNOT394 route product structure diagram
    ACWNOT39437454-52-7
Inquiry

2. ACWNOT394 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYNAM750 route compound structure diagram
    ACYNAM7501820-81-1 In Stock
  4. Then
  5. ACWNOT394 route product structure diagram
    ACWNOT39437454-52-7
Inquiry

Comments (0)